ACQUIREDStale
Corcept Therapeutics Inc · NASDAQ
+138 sh · $15.6K
Filed 3 Sept 2026SEC Form 4view source
- REDUCEDStale
Corcept Therapeutics Inc · NASDAQ
−102 sh · $11.6K
Filed 3 Sept 2026SEC Form 4view source - ACQUIREDStale
Corcept Therapeutics Inc · NASDAQ
+138 sh
Filed 3 Sept 2026SEC Form 4view source